Share Price and Basic Stock Data
Last Updated: January 2, 2026, 8:15 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Quick Heal Technologies Ltd operates in the IT Consulting & Software sector, with a current market capitalization of ₹1,463 Cr and a share price of ₹269. The company has reported fluctuating sales over the past quarters, with the highest quarterly sales of ₹100.94 Cr recorded in September 2022, followed by a notable decline to ₹49.28 Cr in March 2023. However, sales showed signs of recovery, rising to ₹78.36 Cr in September 2023 and ₹81.92 Cr in December 2023. Annual sales figures for the fiscal year ended March 2023 stood at ₹278 Cr, a decline from the previous year’s ₹342 Cr. The trailing twelve months (TTM) revenue is reported at ₹276 Cr, indicating persistent challenges in maintaining growth. The company’s operational performance has been inconsistent, with quarterly sales often impacted by rising expenses, which stood at ₹66.52 Cr in June 2023. The company’s sales recovery efforts will be essential in steering it back towards a growth trajectory.
Profitability and Efficiency Metrics
Profitability metrics for Quick Heal Technologies have shown significant volatility, with a recorded net profit of ₹22.16 Cr in September 2022, which subsequently turned negative in the following quarters, culminating in a net profit of ₹7.91 Cr in September 2025. The operating profit margin (OPM) has fluctuated dramatically, reaching a peak of 28.12% in September 2022 but dropping to -17.00% by June 2025. The company reported a net profit margin of 1.80% for the fiscal year 2025, down from 8.30% in the prior year. Efficiency ratios reveal a cash conversion cycle (CCC) of 218 days for March 2025, indicating potential inefficiencies in managing receivables and inventory. The interest coverage ratio (ICR) stands at a robust 64.45x, reflecting the absence of debt and the company’s ability to cover interest expenses comfortably. However, the inconsistent profitability trends highlight a need for strategic operational improvements to enhance margins and overall financial health.
Balance Sheet Strength and Financial Ratios
Quick Heal Technologies has maintained a strong balance sheet, with total reserves of ₹392 Cr and no recorded borrowings, indicating a debt-free status. The company’s equity capital is reported at ₹54 Cr as of March 2025, with substantial reserves accumulated over the years. The price-to-book value (P/BV) ratio stands at 3.51x, suggesting that the market values the company significantly higher than its book value, a common scenario in the tech sector. However, the return on equity (ROE) is low at 0.63%, and return on capital employed (ROCE) is at 0.24%, indicating underperformance relative to capital invested. The current ratio is reported at 4.72x, reflecting a strong liquidity position, while the quick ratio stands at 4.69x, confirming the company’s ability to meet short-term obligations. Despite a solid balance sheet, the weak profitability ratios raise concerns about the company’s ability to generate adequate returns for shareholders in the near term.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Quick Heal Technologies reveals a strong promoter presence, with promoters holding 71.63% of the equity as of September 2025. This level of ownership may instill confidence among investors regarding the company’s strategic direction. Foreign Institutional Investors (FIIs) have seen a decline in their holdings, dropping to 0.50% from a peak of 2.17% in December 2022, which may reflect waning investor confidence in the stock’s performance. Domestic Institutional Investors (DIIs) hold 2.33%, while public shareholding stands at 25.53%. The total number of shareholders has increased to 55,910, indicating growing retail interest. However, the declining FII participation could be a warning sign for potential investors, suggesting that institutional confidence is faltering as the company grapples with profitability challenges. This dynamic could influence market sentiment and affect the stock’s performance in the future.
Outlook, Risks, and Final Insight
The outlook for Quick Heal Technologies hinges on its ability to stabilize revenue growth and improve profitability. The company’s strong balance sheet and debt-free status are significant strengths, providing a buffer against financial distress. However, ongoing operational inefficiencies and declining profit margins pose substantial risks. The potential for recovery in sales, coupled with effective cost management strategies, could enhance profitability. Conversely, if the company fails to address its operational challenges, continued losses may lead to further declines in investor confidence, especially among FIIs. The future trajectory will depend on the management’s ability to implement strategic initiatives aimed at bolstering revenue and controlling costs. In a competitive landscape, Quick Heal Technologies must leverage its technological expertise and market position to navigate these challenges effectively and restore faith among investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 59.2 Cr. | 18.7 | 18.7/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 149 Cr. | 138 | 194/99.8 | 22.8 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 38.3 Cr. | 299 | 310/140 | 27.4 | 26.7 | 0.33 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.71 Cr. | 1.06 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,275.36 Cr | 554.45 | 88.33 | 123.78 | 0.55% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100.94 | 66.80 | 49.28 | 51.44 | 78.36 | 81.92 | 80.03 | 70.29 | 73.49 | 70.61 | 65.14 | 57.23 | 83.52 |
| Expenses | 72.56 | 78.17 | 65.45 | 66.52 | 67.39 | 70.30 | 69.99 | 67.70 | 70.42 | 74.38 | 73.62 | 66.96 | 74.29 |
| Operating Profit | 28.38 | -11.37 | -16.17 | -15.08 | 10.97 | 11.62 | 10.04 | 2.59 | 3.07 | -3.77 | -8.48 | -9.73 | 9.23 |
| OPM % | 28.12% | -17.02% | -32.81% | -29.32% | 14.00% | 14.18% | 12.55% | 3.68% | 4.18% | -5.34% | -13.02% | -17.00% | 11.05% |
| Other Income | 5.40 | 3.47 | 10.06 | 4.73 | 5.69 | 4.15 | 6.82 | 5.06 | 5.20 | 4.91 | 5.60 | 5.75 | 4.38 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 |
| Depreciation | 4.14 | 4.17 | 3.73 | 2.93 | 3.25 | 3.24 | 3.18 | 2.79 | 3.15 | 3.39 | 3.63 | 2.96 | 3.28 |
| Profit before tax | 29.64 | -12.07 | -9.84 | -13.28 | 13.41 | 12.53 | 13.55 | 4.81 | 5.07 | -2.31 | -6.57 | -7.00 | 10.28 |
| Tax % | 25.24% | -23.03% | -32.52% | -3.92% | 3.80% | 19.71% | -3.62% | 16.22% | 18.15% | -104.76% | -50.53% | -21.29% | 23.05% |
| Net Profit | 22.16 | -9.29 | -6.64 | -12.76 | 12.90 | 10.06 | 14.04 | 4.03 | 4.15 | 0.11 | -3.25 | -5.51 | 7.91 |
| EPS in Rs | 3.82 | -1.75 | -1.25 | -2.40 | 2.43 | 1.89 | 2.62 | 0.75 | 0.77 | 0.02 | -0.60 | -1.02 | 1.46 |
Last Updated: December 29, 2025, 11:03 am
Below is a detailed analysis of the quarterly data for Quick Heal Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 83.52 Cr.. The value appears strong and on an upward trend. It has increased from 57.23 Cr. (Jun 2025) to 83.52 Cr., marking an increase of 26.29 Cr..
- For Expenses, as of Sep 2025, the value is 74.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.96 Cr. (Jun 2025) to 74.29 Cr., marking an increase of 7.33 Cr..
- For Operating Profit, as of Sep 2025, the value is 9.23 Cr.. The value appears strong and on an upward trend. It has increased from -9.73 Cr. (Jun 2025) to 9.23 Cr., marking an increase of 18.96 Cr..
- For OPM %, as of Sep 2025, the value is 11.05%. The value appears strong and on an upward trend. It has increased from -17.00% (Jun 2025) to 11.05%, marking an increase of 28.05%.
- For Other Income, as of Sep 2025, the value is 4.38 Cr.. The value appears to be declining and may need further review. It has decreased from 5.75 Cr. (Jun 2025) to 4.38 Cr., marking a decrease of 1.37 Cr..
- For Interest, as of Sep 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Jun 2025) to 0.05 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 3.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.96 Cr. (Jun 2025) to 3.28 Cr., marking an increase of 0.32 Cr..
- For Profit before tax, as of Sep 2025, the value is 10.28 Cr.. The value appears strong and on an upward trend. It has increased from -7.00 Cr. (Jun 2025) to 10.28 Cr., marking an increase of 17.28 Cr..
- For Tax %, as of Sep 2025, the value is 23.05%. The value appears to be increasing, which may not be favorable. It has increased from -21.29% (Jun 2025) to 23.05%, marking an increase of 44.34%.
- For Net Profit, as of Sep 2025, the value is 7.91 Cr.. The value appears strong and on an upward trend. It has increased from -5.51 Cr. (Jun 2025) to 7.91 Cr., marking an increase of 13.42 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.46. The value appears strong and on an upward trend. It has increased from -1.02 (Jun 2025) to 1.46, marking an increase of 2.48.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 243 | 286 | 302 | 300 | 318 | 315 | 286 | 333 | 342 | 278 | 292 | 280 | 276 |
| Expenses | 157 | 194 | 200 | 210 | 198 | 187 | 195 | 192 | 235 | 276 | 274 | 286 | 289 |
| Operating Profit | 85 | 92 | 102 | 90 | 120 | 128 | 92 | 141 | 107 | 2 | 18 | -7 | -13 |
| OPM % | 35% | 32% | 34% | 30% | 38% | 41% | 32% | 42% | 31% | 1% | 6% | -2% | -5% |
| Other Income | 11 | 8 | 10 | 25 | 30 | 33 | 31 | 24 | 19 | 22 | 21 | 21 | 21 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 20 | 24 | 31 | 27 | 24 | 22 | 19 | 17 | 16 | 13 | 13 | 13 |
| Profit before tax | 86 | 80 | 88 | 84 | 123 | 137 | 101 | 146 | 109 | 8 | 26 | 1 | -6 |
| Tax % | 32% | 33% | 34% | 37% | 33% | 33% | 27% | 27% | 23% | 20% | 8% | -404% | |
| Net Profit | 58 | 54 | 58 | 53 | 83 | 92 | 74 | 107 | 83 | 6 | 24 | 5 | -1 |
| EPS in Rs | 9.56 | 8.81 | 8.27 | 7.59 | 11.79 | 13.01 | 11.59 | 16.66 | 14.34 | 1.21 | 4.53 | 0.93 | -0.14 |
| Dividend Payout % | 78% | 85% | 30% | 33% | 25% | 15% | 35% | 24% | 31% | 207% | 66% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -6.90% | 7.41% | -8.62% | 56.60% | 10.84% | -19.57% | 44.59% | -22.43% | -92.77% | 300.00% | -79.17% |
| Change in YoY Net Profit Growth (%) | 0.00% | 14.30% | -16.03% | 65.22% | -45.76% | -30.41% | 64.16% | -67.02% | -70.34% | 392.77% | -379.17% |
Quick Heal Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -41% |
| 3 Years: | -60% |
| TTM: | -111% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 11% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 8% |
| 3 Years: | 2% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 12:50 pm
Balance Sheet
Last Updated: December 10, 2025, 3:17 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 61 | 61 | 70 | 70 | 70 | 71 | 64 | 64 | 58 | 53 | 54 | 54 | 54 |
| Reserves | 271 | 270 | 559 | 592 | 653 | 719 | 580 | 687 | 570 | 367 | 383 | 387 | 392 |
| Borrowings | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | -0 |
| Other Liabilities | 47 | 97 | 88 | 72 | 57 | 63 | 52 | 75 | 88 | 74 | 76 | 83 | 99 |
| Total Liabilities | 380 | 428 | 717 | 734 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 545 |
| Fixed Assets | 82 | 111 | 142 | 185 | 173 | 165 | 158 | 146 | 137 | 124 | 117 | 119 | 117 |
| CWIP | 55 | 74 | 55 | 14 | 14 | 11 | 3 | 2 | -0 | 0 | 3 | 0 | 9 |
| Investments | 131 | 130 | 115 | 182 | 306 | 390 | 310 | 416 | 318 | 198 | 190 | 179 | 185 |
| Other Assets | 111 | 113 | 405 | 353 | 287 | 288 | 225 | 263 | 261 | 171 | 203 | 226 | 234 |
| Total Assets | 380 | 428 | 717 | 734 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 545 |
Below is a detailed analysis of the balance sheet data for Quick Heal Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 54.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 54.00 Cr..
- For Reserves, as of Sep 2025, the value is 392.00 Cr.. The value appears strong and on an upward trend. It has increased from 387.00 Cr. (Mar 2025) to 392.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 99.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 83.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 16.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 545.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 525.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 20.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 117.00 Cr.. The value appears to be declining and may need further review. It has decreased from 119.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 185.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2025) to 185.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 234.00 Cr.. The value appears strong and on an upward trend. It has increased from 226.00 Cr. (Mar 2025) to 234.00 Cr., marking an increase of 8.00 Cr..
- For Total Assets, as of Sep 2025, the value is 545.00 Cr.. The value appears strong and on an upward trend. It has increased from 525.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 20.00 Cr..
Notably, the Reserves (392.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 85.00 | 92.00 | 102.00 | 90.00 | 120.00 | 128.00 | 92.00 | 141.00 | 107.00 | 2.00 | 18.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 104 | 83 | 112 | 118 | 118 | 145 | 144 | 165 | 184 | 161 | 165 | 218 |
| Inventory Days | 181 | 144 | ||||||||||
| Days Payable | 864 | 1,103 | ||||||||||
| Cash Conversion Cycle | 104 | -600 | -847 | 118 | 118 | 145 | 144 | 165 | 184 | 161 | 165 | 218 |
| Working Capital Days | 52 | -23 | 29 | 49 | 70 | 92 | 94 | 98 | 102 | 83 | 88 | 354 |
| ROCE % | 27% | 24% | 18% | 14% | 18% | 18% | 14% | 21% | 15% | 0% | 6% | 0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Digital India Fund | 425,000 | 0.11 | 13.07 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.94 | 4.56 | 1.14 | 14.01 | 16.66 |
| Diluted EPS (Rs.) | 0.91 | 4.48 | 1.14 | 13.94 | 16.65 |
| Cash EPS (Rs.) | 3.33 | 6.88 | 4.22 | 17.34 | 19.70 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 81.75 | 81.67 | 79.09 | 108.19 | 117.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 81.75 | 81.67 | 79.09 | 108.19 | 117.04 |
| Revenue From Operations / Share (Rs.) | 51.76 | 54.52 | 52.40 | 58.94 | 51.87 |
| PBDIT / Share (Rs.) | 2.63 | 7.28 | 4.52 | 21.73 | 25.80 |
| PBIT / Share (Rs.) | 0.22 | 4.92 | 1.51 | 18.73 | 22.76 |
| PBT / Share (Rs.) | 0.18 | 4.90 | 1.51 | 18.73 | 22.76 |
| Net Profit / Share (Rs.) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 |
| NP After MI And SOA / Share (Rs.) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 |
| PBDIT Margin (%) | 5.07 | 13.34 | 8.63 | 36.87 | 49.73 |
| PBIT Margin (%) | 0.43 | 9.02 | 2.88 | 31.78 | 43.87 |
| PBT Margin (%) | 0.35 | 8.98 | 2.88 | 31.78 | 43.87 |
| Net Profit Margin (%) | 1.80 | 8.30 | 2.30 | 24.33 | 32.12 |
| NP After MI And SOA Margin (%) | 1.80 | 8.30 | 2.30 | 24.33 | 32.12 |
| Return on Networth / Equity (%) | 1.14 | 5.54 | 1.52 | 13.25 | 14.23 |
| Return on Capital Employeed (%) | 0.27 | 5.99 | 1.90 | 17.25 | 19.41 |
| Return On Assets (%) | 0.95 | 4.72 | 1.29 | 11.62 | 12.94 |
| Asset Turnover Ratio (%) | 0.53 | 0.58 | 0.46 | 0.44 | 0.43 |
| Current Ratio (X) | 4.72 | 4.96 | 4.50 | 6.20 | 8.53 |
| Quick Ratio (X) | 4.69 | 4.93 | 4.43 | 6.15 | 8.49 |
| Inventory Turnover Ratio (X) | 111.37 | 0.11 | 0.23 | 0.24 | 0.21 |
| Dividend Payout Ratio (NP) (%) | 320.03 | 54.74 | 407.96 | 27.85 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 89.61 | 36.02 | 116.61 | 23.03 | 0.00 |
| Earning Retention Ratio (%) | -220.03 | 45.26 | -307.96 | 72.15 | 0.00 |
| Cash Earning Retention Ratio (%) | 10.39 | 63.98 | -16.61 | 76.97 | 0.00 |
| Interest Coverage Ratio (X) | 64.45 | 299.54 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 23.91 | 187.46 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 1527.48 | 2480.96 | 695.04 | 966.92 | 1113.79 |
| EV / Net Operating Revenue (X) | 5.46 | 8.50 | 2.50 | 2.83 | 3.34 |
| EV / EBITDA (X) | 107.72 | 63.71 | 28.95 | 7.67 | 6.72 |
| MarketCap / Net Operating Revenue (X) | 5.54 | 8.63 | 2.54 | 3.01 | 3.60 |
| Retention Ratios (%) | -220.03 | 45.25 | -307.96 | 72.14 | 0.00 |
| Price / BV (X) | 3.51 | 5.76 | 1.68 | 1.64 | 1.59 |
| Price / Net Operating Revenue (X) | 5.54 | 8.63 | 2.54 | 3.01 | 3.60 |
| EarningsYield | 0.00 | 0.01 | 0.01 | 0.08 | 0.08 |
After reviewing the key financial ratios for Quick Heal Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 5. It has decreased from 4.56 (Mar 24) to 0.94, marking a decrease of 3.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 5. It has decreased from 4.48 (Mar 24) to 0.91, marking a decrease of 3.57.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.33. This value is within the healthy range. It has decreased from 6.88 (Mar 24) to 3.33, marking a decrease of 3.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.75. It has increased from 81.67 (Mar 24) to 81.75, marking an increase of 0.08.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.75. It has increased from 81.67 (Mar 24) to 81.75, marking an increase of 0.08.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.76. It has decreased from 54.52 (Mar 24) to 51.76, marking a decrease of 2.76.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.63. This value is within the healthy range. It has decreased from 7.28 (Mar 24) to 2.63, marking a decrease of 4.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 0.22, marking a decrease of 4.70.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.18. This value is within the healthy range. It has decreased from 4.90 (Mar 24) to 0.18, marking a decrease of 4.72.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 2. It has decreased from 4.53 (Mar 24) to 0.93, marking a decrease of 3.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 2. It has decreased from 4.53 (Mar 24) to 0.93, marking a decrease of 3.60.
- For PBDIT Margin (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 10. It has decreased from 13.34 (Mar 24) to 5.07, marking a decrease of 8.27.
- For PBIT Margin (%), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 10. It has decreased from 9.02 (Mar 24) to 0.43, marking a decrease of 8.59.
- For PBT Margin (%), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 10. It has decreased from 8.98 (Mar 24) to 0.35, marking a decrease of 8.63.
- For Net Profit Margin (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 5. It has decreased from 8.30 (Mar 24) to 1.80, marking a decrease of 6.50.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 8. It has decreased from 8.30 (Mar 24) to 1.80, marking a decrease of 6.50.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 15. It has decreased from 5.54 (Mar 24) to 1.14, marking a decrease of 4.40.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 10. It has decreased from 5.99 (Mar 24) to 0.27, marking a decrease of 5.72.
- For Return On Assets (%), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 4.72 (Mar 24) to 0.95, marking a decrease of 3.77.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.53. It has decreased from 0.58 (Mar 24) to 0.53, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 4.72. This value exceeds the healthy maximum of 3. It has decreased from 4.96 (Mar 24) to 4.72, marking a decrease of 0.24.
- For Quick Ratio (X), as of Mar 25, the value is 4.69. This value exceeds the healthy maximum of 2. It has decreased from 4.93 (Mar 24) to 4.69, marking a decrease of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 111.37. This value exceeds the healthy maximum of 8. It has increased from 0.11 (Mar 24) to 111.37, marking an increase of 111.26.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 320.03. This value exceeds the healthy maximum of 50. It has increased from 54.74 (Mar 24) to 320.03, marking an increase of 265.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 89.61. This value exceeds the healthy maximum of 50. It has increased from 36.02 (Mar 24) to 89.61, marking an increase of 53.59.
- For Earning Retention Ratio (%), as of Mar 25, the value is -220.03. This value is below the healthy minimum of 40. It has decreased from 45.26 (Mar 24) to -220.03, marking a decrease of 265.29.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 10.39. This value is below the healthy minimum of 40. It has decreased from 63.98 (Mar 24) to 10.39, marking a decrease of 53.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 64.45. This value is within the healthy range. It has decreased from 299.54 (Mar 24) to 64.45, marking a decrease of 235.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.91. This value is within the healthy range. It has decreased from 187.46 (Mar 24) to 23.91, marking a decrease of 163.55.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,527.48. It has decreased from 2,480.96 (Mar 24) to 1,527.48, marking a decrease of 953.48.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.46. This value exceeds the healthy maximum of 3. It has decreased from 8.50 (Mar 24) to 5.46, marking a decrease of 3.04.
- For EV / EBITDA (X), as of Mar 25, the value is 107.72. This value exceeds the healthy maximum of 15. It has increased from 63.71 (Mar 24) to 107.72, marking an increase of 44.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.54. This value exceeds the healthy maximum of 3. It has decreased from 8.63 (Mar 24) to 5.54, marking a decrease of 3.09.
- For Retention Ratios (%), as of Mar 25, the value is -220.03. This value is below the healthy minimum of 30. It has decreased from 45.25 (Mar 24) to -220.03, marking a decrease of 265.28.
- For Price / BV (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 3. It has decreased from 5.76 (Mar 24) to 3.51, marking a decrease of 2.25.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.54. This value exceeds the healthy maximum of 3. It has decreased from 8.63 (Mar 24) to 5.54, marking a decrease of 3.09.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Quick Heal Technologies Ltd:
- Net Profit Margin: 1.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.27% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.14% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 23.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 88.33)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Solitaire Business Hub, Pune Maharashtra 411014 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Kailash Sahebrao Katkar | Chairman & Managing Director |
| Dr. Sanjay Sahebrao Katkar | Joint Managing Director |
| Mr. Shailesh Lakhani | Non Executive Director |
| Mr. Amitabha Mukhopadhyay | Independent Director |
| Air M'shal (Retd.) Bhushan Nilkanth Gokhale | Independent Director |
| Ms. Apurva Pradeep Joshi | Independent Director |
| Mr. Richard Stiennon | Independent Director |
| Mr. Kamal Kumar Agarwal | Independent Director |
FAQ
What is the intrinsic value of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd's intrinsic value (as of 03 January 2026) is ₹6.36 which is 97.64% lower the current market price of ₹269.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,463 Cr. market cap, FY2025-2026 high/low of ₹680/245, reserves of ₹392 Cr, and liabilities of ₹545 Cr.
What is the Market Cap of Quick Heal Technologies Ltd?
The Market Cap of Quick Heal Technologies Ltd is 1,463 Cr..
What is the current Stock Price of Quick Heal Technologies Ltd as on 03 January 2026?
The current stock price of Quick Heal Technologies Ltd as on 03 January 2026 is ₹269.
What is the High / Low of Quick Heal Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Quick Heal Technologies Ltd stocks is ₹680/245.
What is the Stock P/E of Quick Heal Technologies Ltd?
The Stock P/E of Quick Heal Technologies Ltd is .
What is the Book Value of Quick Heal Technologies Ltd?
The Book Value of Quick Heal Technologies Ltd is 82.5.
What is the Dividend Yield of Quick Heal Technologies Ltd?
The Dividend Yield of Quick Heal Technologies Ltd is 0.00 %.
What is the ROCE of Quick Heal Technologies Ltd?
The ROCE of Quick Heal Technologies Ltd is 0.24 %.
What is the ROE of Quick Heal Technologies Ltd?
The ROE of Quick Heal Technologies Ltd is 0.63 %.
What is the Face Value of Quick Heal Technologies Ltd?
The Face Value of Quick Heal Technologies Ltd is 10.0.